Alejandro Parra Virto

Transient ischaemic attack after spacing the dose of alirocumab: Is it advisable to reduce the doses of PCSK9 inhibitors with very low LDL-cholesterols?

Sandra Piqueras Ruiz, Alejandro Parra Virto, A. Torres do Rego, 2020, Clínica e Investigación en Arteriosclerosis (English Edition).

Risk Categories in COVID-19 Based on Degrees of Inflammation: Data on More Than 17,000 Patients from the Spanish SEMI-COVID-19 Registry

F. Formiga, X. Corbella, M. Rubio-Rivas, 2021, Journal of clinical medicine.

Use of antihyperglycaemic therapy with cardiovascular benefit in patients with type 2 diabetes who require hospitalisation: A cross-sectional study.

J. Ena, R. Gómez-Huelgas, M. Folgueras, 2020, Revista clinica espanola.